Login / Signup

Guidelines for management of actual or suspected inadvertent intra-arterial injection of sclerosants.

Kurosh ParsiMarianne De MaeseneerAndre M van RijChristopher RoganWendy BonythonJohn A DevereuxChristopher K LekichMichael AmosAhmet Kursat BozkurtDavid Ewan ConnorAlun Huw DaviesSergio GianesiniKathleen GibsonPeter GloviczkiAnthony GrabsLorena GrilloFranz HafnerDavid HuberMark IafratiMark JacksonRavul JindalAdrian LimFedor LurieLisa MarksPauline Raymond-MartimbeauPeter ParaskevasAlbert-Adrien RameletRodrigo RialStefania RobertsCarlos SimkinPaul K ThibaultMark Steven Whiteley
Published in: Phlebology (2024)
Inadvertent intra-arterial injection is an adverse event of both ultrasound-guided and direct vision sclerotherapy. Medical practitioners performing sclerotherapy must ensure completion of a course of formal training (specialty or subspecialty training, or equivalent recognition) in the management of venous and lymphatic disorders (phlebology), and be personally proficient in the use of duplex ultrasound in vascular (both arterial and venous) applications, to diagnose and provide image guidance to venous procedure. Expertise in diagnosis and immediate management of an intra-arterial injection is essential for all practitioners performing sclerotherapy.
Keyphrases
  • ultrasound guided
  • primary care
  • healthcare
  • magnetic resonance imaging
  • lymph node
  • emergency department
  • pulmonary embolism
  • minimally invasive
  • general practice
  • machine learning
  • medical students